Thus, CD19+/IL-10+/TGFβ+ B lymphocytes were indeed significantly reduced in PPMS patients alone, suggesting that, in analogy with what was observed in murine model of EAE (see above), this subpopulation of immune cells plays an important role in controlling the inflammation which characterizes this disease. The gene discussed is CD19; the disease is primary progressive multiple sclerosis.